ID | Name | Number of studies | |
---|---|---|---|
CL_0000164 | enteroendocrine cell | 18 | |
CL_0000171 | pancreatic A cell | 4 |
Gene | Number of supported studies | Average coverage | Other major groups (express this gene) | Other cell types (express this gene) | |
---|---|---|---|---|---|
GCG | 4 | 98% ± 2% | 0 | 0 | |
CRYBA2 | 4 | 77% ± 8% | 0 | 1 | |
SLC30A8 | 4 | 58% ± 24% | 0 | 2 | |
SCGN | 4 | 77% ± 11% | 0 | 4 | |
C2CD4A | 3 | 35% ± 11% | 0 | 0 | |
CRH | 3 | 23% ± 5% | 0 | 0 | |
DIRAS3 | 3 | 25% ± 2% | 0 | 0 | |
FEV | 3 | 53% ± 14% | 0 | 1 | |
CNIH2 | 3 | 43% ± 28% | 0 | 2 | |
SST | 3 | 75% ± 23% | 0 | 2 | |
VGF | 4 | 82% ± 18% | 1 | 2 | |
RGS4 | 4 | 54% ± 27% | 1 | 3 | |
SYT5 | 4 | 29% ± 7% | 1 | 3 | |
ISL1 | 4 | 45% ± 24% | 1 | 6 | |
RAB3B | 4 | 60% ± 24% | 1 | 6 | |
NEUROD1 | 4 | 56% ± 21% | 1 | 8 | |
SYT4 | 4 | 36% ± 17% | 1 | 8 | |
CHGA | 4 | 93% ± 9% | 1 | 9 | |
PTPRN | 4 | 82% ± 14% | 1 | 9 | |
KCNK3 | 3 | 31% ± 9% | 1 | 1 | |
DUSP8 | 3 | 22% ± 6% | 1 | 1 | |
LOXL4 | 3 | 45% ± 25% | 1 | 1 | |
FAM104B | 3 | 23% ± 6% | 1 | 2 | |
WNT4 | 3 | 32% ± 10% | 1 | 2 | |
STX1A | 3 | 46% ± 4% | 1 | 2 | |
GC | 4 | 89% ± 7% | 2 | 2 | |
PPP1R1A | 4 | 56% ± 21% | 2 | 4 | |
F10 | 4 | 50% ± 9% | 2 | 5 | |
SCGB2A1 | 4 | 47% ± 13% | 2 | 5 | |
BEX5 | 4 | 35% ± 7% | 2 | 5 |
GO_1900118 | Biological process | negative regulation of execution phase of apoptosis |
GO_0062111 | Biological process | zinc ion import into organelle |
GO_0051917 | Biological process | regulation of fibrinolysis |
GO_0008628 | Biological process | hormone-mediated apoptotic signaling pathway |
GO_1905604 | Biological process | negative regulation of blood-brain barrier permeability |
GO_0006892 | Biological process | post-Golgi vesicle-mediated transport |
GO_0099072 | Biological process | regulation of postsynaptic membrane neurotransmitter receptor levels |
GO_0034197 | Biological process | triglyceride transport |
GO_0033033 | Biological process | negative regulation of myeloid cell apoptotic process |
GO_0061052 | Biological process | negative regulation of cell growth involved in cardiac muscle cell development |
GO_0032940 | Biological process | secretion by cell |
GO_0048599 | Biological process | oocyte development |
GO_0099538 | Biological process | synaptic signaling via neuropeptide |
GO_0006972 | Biological process | hyperosmotic response |
GO_0001692 | Biological process | histamine metabolic process |
GO_0015853 | Biological process | adenine transport |
GO_0010807 | Biological process | regulation of synaptic vesicle priming |
GO_0048278 | Biological process | vesicle docking |
GO_0071377 | Biological process | cellular response to glucagon stimulus |
GO_0045956 | Biological process | positive regulation of calcium ion-dependent exocytosis |
GO_0033605 | Biological process | positive regulation of catecholamine secretion |
GO_0019953 | Biological process | sexual reproduction |
GO_1990791 | Biological process | dorsal root ganglion development |
GO_0110095 | Biological process | cellular detoxification of aldehyde |
GO_0001956 | Biological process | positive regulation of neurotransmitter secretion |
GO_0035461 | Biological process | vitamin transmembrane transport |
GO_0043269 | Biological process | regulation of monoatomic ion transport |
GO_0071578 | Biological process | zinc ion import across plasma membrane |
GO_0031629 | Biological process | synaptic vesicle fusion to presynaptic active zone membrane |
GO_0030070 | Biological process | insulin processing |
Cell type name | pancreatic A cell |
Synonyms | alpha cell of islet of Langerhans pancreatic alpha cell |
Description | A type of enteocrine cell found in the periphery of the islets of Langerhans that secretes glucagon. |
Parent | CL_0000164 |